DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1093648
Title:
Follistatin: A Potential Anabolic Treatment for Re-innervated Muscle
Corporate Author:
Virginia Commonwealth University Richmond United States
Report Date:
2019-02-01
Abstract:
Follistatin is a possible anabolic treatment for denervation atrophy induced muscle weakness following prolonged denervation. Follistatin DNA treatment seemed to have both anabolic and neurotrophic effects when administered after nerve repair following prolonged 6-month temporary denervation. Follistatin protein treatment was not associated with improved recovery though both protein and DNA treatments stimulated regenerative satellite cells. These observations are encouraging and warrant further investigation.
Descriptive Note:
Technical Report,15 Aug 2015,14 Nov 2018
Pages:
0034
Distribution Statement:
Approved For Public Release;
File Size:
1.40MB